DE SANTIS, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 1.605
AS - Asia 813
EU - Europa 748
SA - Sud America 180
Continente sconosciuto - Info sul continente non disponibili 44
AF - Africa 12
OC - Oceania 1
Totale 3.403
Nazione #
US - Stati Uniti d'America 1.537
SG - Singapore 334
RU - Federazione Russa 229
IT - Italia 223
BR - Brasile 149
VN - Vietnam 115
CN - Cina 109
BD - Bangladesh 94
HK - Hong Kong 73
DE - Germania 72
FI - Finlandia 41
CA - Canada 40
FR - Francia 36
GB - Regno Unito 34
NL - Olanda 26
MX - Messico 19
IN - India 18
AT - Austria 16
AR - Argentina 15
ES - Italia 15
PL - Polonia 12
IE - Irlanda 11
JP - Giappone 11
IQ - Iraq 7
TR - Turchia 7
UZ - Uzbekistan 7
SA - Arabia Saudita 6
CZ - Repubblica Ceca 5
PK - Pakistan 5
SE - Svezia 5
VE - Venezuela 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
KZ - Kazakistan 4
UA - Ucraina 4
EC - Ecuador 3
GT - Guatemala 3
KE - Kenya 3
PH - Filippine 3
PT - Portogallo 3
RS - Serbia 3
BE - Belgio 2
CL - Cile 2
EG - Egitto 2
HU - Ungheria 2
ID - Indonesia 2
LT - Lituania 2
MY - Malesia 2
PA - Panama 2
TH - Thailandia 2
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
Totale 3.359
Città #
Dallas 454
Singapore 216
San Jose 173
Ashburn 131
Council Bluffs 94
Hong Kong 68
Santa Clara 57
New York 54
Los Angeles 49
Ho Chi Minh City 41
The Dalles 35
Munich 33
Hanoi 30
Beijing 29
Verona 28
Moscow 24
Boardman 23
Lauterbourg 21
Lappeenranta 19
São Paulo 19
Montreal 18
Milan 17
Rome 17
Denver 16
Benevento 15
Toronto 15
Orem 13
Brooklyn 12
Hefei 12
Helsinki 12
Dublin 11
Mexico City 11
Poplar 11
Atlanta 10
San Francisco 10
Turku 10
Warsaw 10
Chicago 9
Falkenstein 9
London 9
L’Aquila 9
Da Nang 8
Düsseldorf 8
Florence 8
Seattle 8
Tokyo 8
Boston 7
Buffalo 7
Kitzingen 7
Shanghai 7
Vienna 7
Curitiba 6
Frankfurt am Main 6
Phoenix 6
Tashkent 6
Ankara 5
Charlotte 5
Chennai 5
Houston 5
Jinan 5
Portsmouth 5
Amsterdam 4
Bologna 4
Campinas 4
Changsha 4
Haiphong 4
Mumbai 4
Piscataway 4
Querétaro 4
Rio de Janeiro 4
Stockholm 4
Thái Nguyên 4
West Jordan 4
Annapolis 3
Braga 3
Catania 3
Fort Worth 3
Johannesburg 3
Lahore 3
Manchester 3
Nairobi 3
Naples 3
Olomouc 3
Pescara 3
Raleigh 3
Santo André 3
Spoltore 3
St Louis 3
Teramo 3
Thái Bình 3
Waterbury 3
Agropoli 2
Aparecida 2
Astana 2
Bauru 2
Belgrade 2
Brno 2
Brussels 2
Bắc Ninh 2
Can Tho 2
Totale 2.103
Nome #
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 359
Do antithrombotic drugs have a role in migraine prevention? A systematic review 331
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis 143
Real‐World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study 127
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 109
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 108
Impact of duration of chronic migraine on long‐term effectiveness of monoclonal antibodies targeting the calcitonin gene‐related peptide pathway—A real‐world study 104
Effectiveness of transcranial direct current stimulation and monoclonal antibodies acting on the CGRP as a combined treatment for migraine (TACTIC): Results of a randomized controlled trial 104
Effectiveness and tolerability of atogepant in the prevention of migraine: A real life, prospective, multicentric study (the STAR study) 103
A REAl-life study on short-term Dual Antiplatelet treatment in Patients with ischemic stroke or Transient ischemic attack (READAPT) 101
Epidemiology and treatment of atraumatic subarachnoid hemorrhage over 10 years in a population-based registry 97
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: a propensity matched analysis 96
Association of anti‐calcitonin gene‐related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort study 95
Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis 94
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 92
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 91
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 90
Sex Differences in the Epidemiology of Intracerebral Hemorrhage Over 10 Years in a Population‐Based Stroke Registry 85
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 84
Risk of stroke with different levels of leisure-time physical activity: a systematic review and meta-analysis of prospective cohort studies 83
Incidence and prognosis of first-ever intracerebral hemorrhage on antiplatelet therapy over 10 years in a population-based stroke registry 81
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 80
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities 74
Clinical characteristics and outcomes of ischemic stroke despite appropriate oral anticoagulation for atrial fibrillation: A systematic review and meta-analysis of real-world studies 73
Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder 67
A call for academic pragmatic clinical trials to address open questions in migraine prevention 65
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging: Results from the READAPT study 64
Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry 58
Migraine with aura, thrombophilia, and the debate on white matter hyperintensities 54
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study 54
Acute Treatment of Disabling and Nondisabling Minor Ischemic Stroke: Expert Guidance for Clinicians 48
Sex differences in the clinical features of 2,841 patients with migraine: a post-hoc, multicenter, cross-sectional study 38
The potential role of sleep quality in the relationship between glymphatic function and migraine frequency: Insights from a cross-sectional study 33
Atrial fibrillation detection after Embolic Stroke of Undetermined Source: development and validation of the CATCH-AF score 30
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke 27
Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial Fibrillation 24
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted Analysis 14
Timing of insertable cardiac monitor implantation after embolic stroke of undetermined source and its impact on atrial fibrillation detection: A target trial emulation analysis 9
null 7
Translation and validation of the Migraine Interictal Burden Scale (MIBS-4) in an Italian clinical cohort 7
Totale 3.403
Categoria #
all - tutte 11.794
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.794


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202318 0 0 0 0 0 0 0 1 10 1 3 3
2023/202469 2 2 5 5 3 8 0 4 2 13 3 22
2024/2025665 20 5 32 35 59 48 89 50 137 48 77 65
2025/20262.221 74 405 147 272 203 105 211 96 166 276 159 107
2026/2027430 117 313 0 0 0 0 0 0 0 0 0 0
Totale 3.403